Bioengineered Protein Drugs Market by Drugs Type ( Monoclonal Antibodies, Therapeutic Proteins, Vaccines) by Therapy (Endocrinology, Immunology, Hematology, Infectiology, Neurology, Oncology, Genetic disorder) by Application (Diabetes mellitus, Rheumatoid arthritis or Crohn’s disease, Anemia, Vaccination, Multiple sclerosis, Colon and Breast cancer, Cystic fibrosis ) by End User (Pharma and Biotech Companies, CROs, Academics) by Industry Analysis, Volume, Share, Growth, Challenges, Trends and Forecast 2018–2026

1 Bioengineered Protein Drugs Market Overview

1.1 Product Overview and Scope of Bioengineered Protein Drugs

1.2 Bioengineered Protein Drugs Segment by Type (Product Category)

1.2.1 Global Bioengineered Protein Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)

1.2.2 Global Bioengineered Protein Drugs Production Market Share by Type (Product Category) in 2016

1.2.3 Monoclonal Antibodies

1.2.4 Therapeutic Proteins

1.2.5 Vaccines

1.3 Global Bioengineered Protein Drugs Segment by Application

1.3.1 Bioengineered Protein Drugs Consumption (Sales) Comparison by Application (2012-2022)

1.3.2 Pharma and Biotech Companies

1.3.3 CROs

1.3.4 Academics

1.4 Global Bioengineered Protein Drugs Market by Region (2012-2022)

1.4.1 Global Bioengineered Protein Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)

1.4.2 North America Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 China Status and Prospect (2012-2022)

1.4.5 Japan Status and Prospect (2012-2022)

1.4.6 Southeast Asia Status and Prospect (2012-2022)

1.4.7 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value) of Bioengineered Protein Drugs (2012-2022)

1.5.1 Global Bioengineered Protein Drugs Revenue Status and Outlook (2012-2022)

1.5.2 Global Bioengineered Protein Drugs Capacity, Production Status and Outlook (2012-2022)

 

2 Global Bioengineered Protein Drugs Market Competition by Manufacturers

2.1 Global Bioengineered Protein Drugs Capacity, Production and Share by Manufacturers (2012-2017)

2.1.1 Global Bioengineered Protein Drugs Capacity and Share by Manufacturers (2012-2017)

2.1.2 Global Bioengineered Protein Drugs Production and Share by Manufacturers (2012-2017)

2.2 Global Bioengineered Protein Drugs Revenue and Share by Manufacturers (2012-2017)

2.3 Global Bioengineered Protein Drugs Average Price by Manufacturers (2012-2017)

2.4 Manufacturers Bioengineered Protein Drugs Manufacturing Base Distribution, Sales Area and Product Type

2.5 Bioengineered Protein Drugs Market Competitive Situation and Trends

2.5.1 Bioengineered Protein Drugs Market Concentration Rate

2.5.2 Bioengineered Protein Drugs Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

 

3 Global Bioengineered Protein Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)

3.1 Global Bioengineered Protein Drugs Capacity and Market Share by Region (2012-2017)

3.2 Global Bioengineered Protein Drugs Production and Market Share by Region (2012-2017)

3.3 Global Bioengineered Protein Drugs Revenue (Value) and Market Share by Region (2012-2017)

3.4 Global Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.5 North America Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.6 Europe Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.7 China Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.8 Japan Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.9 Southeast Asia Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.10 India Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

 

4 Global Bioengineered Protein Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)

4.1 Global Bioengineered Protein Drugs Consumption by Region (2012-2017)

4.2 North America Bioengineered Protein Drugs Production, Consumption, Export, Import (2012-2017)

4.3 Europe Bioengineered Protein Drugs Production, Consumption, Export, Import (2012-2017)

4.4 China Bioengineered Protein Drugs Production, Consumption, Export, Import (2012-2017)

4.5 Japan Bioengineered Protein Drugs Production, Consumption, Export, Import (2012-2017)

4.6 Southeast Asia Bioengineered Protein Drugs Production, Consumption, Export, Import (2012-2017)

4.7 India Bioengineered Protein Drugs Production, Consumption, Export, Import (2012-2017)

 

5 Global Bioengineered Protein Drugs Production, Revenue (Value), Price Trend by Type

5.1 Global Bioengineered Protein Drugs Production and Market Share by Type (2012-2017)

5.2 Global Bioengineered Protein Drugs Revenue and Market Share by Type (2012-2017)

5.3 Global Bioengineered Protein Drugs Price by Type (2012-2017)

5.4 Global Bioengineered Protein Drugs Production Growth by Type (2012-2017)

 

6 Global Bioengineered Protein Drugs Market Analysis by Application

6.1 Global Bioengineered Protein Drugs Consumption and Market Share by Application (2012-2017)

6.2 Global Bioengineered Protein Drugs Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

 

7 Global Bioengineered Protein Drugs Manufacturers Profiles/Analysis

7.1 GlaxoSmithKline

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 Bioengineered Protein Drugs Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 GlaxoSmithKline Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.1.4 Main Business/Business Overview

7.2 Johnson & Johnson

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 Bioengineered Protein Drugs Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 Johnson & Johnson Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.2.4 Main Business/Business Overview

7.3 Merck

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 Bioengineered Protein Drugs Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Merck Bioengineered Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.3.4 Main Business/Business Overview

7.4 Novartis

7.5 Sanofi

7.6 Eli Lilly

7.7 F. Hoffmann-La Roche

7.8 Dr. Reddy’s Laboratories

7.9 Abbott Laboratories

7.10 Amgen

7.11 Bayer AG

7.12 Biocon

7.13 Fresenius kabi

7.14 Panacea Biotec

7.15 ProBioGen AG

7.16 Reliance Life Science

 

8 Bioengineered Protein Drugs Manufacturing Cost Analysis

8.1 Bioengineered Protein Drugs Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Bioengineered Protein Drugs

 

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Bioengineered Protein Drugs Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2015

9.4 Downstream Buyers

 

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

 

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

 

12 Global Bioengineered Protein Drugs Market Forecast (2017-2022)

12.1 Global Bioengineered Protein Drugs Capacity, Production, Revenue Forecast (2017-2022)

12.1.1 Global Bioengineered Protein Drugs Capacity, Production and Growth Rate Forecast (2017-2022)

12.1.2 Global Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2017-2022)

12.1.3 Global Bioengineered Protein Drugs Price and Trend Forecast (2017-2022)

12.2 Global Bioengineered Protein Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)

12.2.1 North America Bioengineered Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.2 Europe Bioengineered Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.3 China Bioengineered Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.4 Japan Bioengineered Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.5 Southeast Asia Bioengineered Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.6 India Bioengineered Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.3 Global Bioengineered Protein Drugs Production, Revenue and Price Forecast by Type (2017-2022)

12.4 Global Bioengineered Protein Drugs Consumption Forecast by Application (2017-2022)

 

13 Research Findings and Conclusion
 

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

 

 

---

List of Tables

1. Table Major Manufacturers of Monoclonal Antibodies

2. Table Major Manufacturers of Therapeutic Proteins

3. Table Major Manufacturers of Vaccines
4. Table Key Downstream Customer in Pharma and Biotech Companies
5. Table Key Downstream Customer in CROs

6. Table Key Downstream Customer in Academics

7. Table Global Bioengineered Protein Drugs Capacity (K Pcs) of Key Manufacturers (2012-2017)

8. Table Global Bioengineered Protein Drugs Capacity Market Share of Key Manufacturers (2012-2017)

9. Table Global Bioengineered Protein Drugs Production (K Pcs) of Key Manufacturers (2012-2017)

10. Table Global Bioengineered Protein Drugs Production Share by Manufacturers (2012-2017)

11. Figure Global Bioengineered Protein Drugs Major Players Product Revenue (Million USD) (2012-2017)

12. Table Global Bioengineered Protein Drugs Revenue (Million USD) by Manufacturers (2012-2017)

13. Table Global Bioengineered Protein Drugs Revenue Share by Manufacturers (2012-2017)

14. Table 2016 Global Bioengineered Protein Drugs Revenue Share by Manufacturers

15. Table 2017 Global Bioengineered Protein Drugs Revenue Share by Manufacturers

16. Table Global Market Bioengineered Protein Drugs Average Price (USD/Pcs) of Key Manufacturers (2012-2017)

17. Table Manufacturers Bioengineered Protein Drugs Manufacturing Base Distribution and Sales Area

18. Table Manufacturers Bioengineered Protein Drugs Product Category

19. Table Global Bioengineered Protein Drugs Capacity (K Pcs) by Region (2012-2017)

20. Table Global Bioengineered Protein Drugs Production by Region (2012-2017)

21. Table Global Bioengineered Protein Drugs Revenue (Million USD) by Region (2012-2017)

22. Table Global Bioengineered Protein Drugs Revenue Market Share by Region (2012-2017)

23. Table 2016 Global Bioengineered Protein Drugs Revenue Market Share by Region

24. Table Global Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

25. Table North America Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

26. Table Europe Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

27. Table China Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

28. Table Japan Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

29. Table Southeast Asia Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

30. Table India Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

31. Table Global Bioengineered Protein Drugs Consumption (K Pcs) Market by Region (2012-2017)

32. Table Global Bioengineered Protein Drugs Consumption Market Share by Region (2012-2017)

33. Table North America Bioengineered Protein Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)

34. Table Europe Bioengineered Protein Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)

35. Table China Bioengineered Protein Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)

36. Table Japan Bioengineered Protein Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)

37. Table Southeast Asia Bioengineered Protein Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)

38. Table India Bioengineered Protein Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)

39. Table Global Bioengineered Protein Drugs Production (K Pcs) by Type (2012-2017)

40. Table Global Bioengineered Protein Drugs Production Share by Type (2012-2017)

41. Table Global Bioengineered Protein Drugs Revenue (Million USD) by Type (2012-2017)

42. Table Global Bioengineered Protein Drugs Revenue Share by Type (2012-2017)

43. Table Global Bioengineered Protein Drugs Price (USD/Pcs) by Type (2012-2017)

44. Table Global Bioengineered Protein Drugs Consumption (K Pcs) by Application (2012-2017)

45. Table Global Bioengineered Protein Drugs Consumption Market Share by Application (2012-2017)
46. Table Global Bioengineered Protein Drugs Consumption Growth Rate by Application (2012-2017)
47. Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors

48. Table GlaxoSmithKline Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

49. Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors

50. Table Johnson & Johnson Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

51. Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors

52. Table Merck Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

53. Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors

54. Table Novartis Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

55. Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors

56. Table Sanofi Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

57. Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors

58. Table Eli Lilly Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

59. Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors

60. Table F. Hoffmann-La Roche Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

61. Table Dr. Reddy’s Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors

62. Table Dr. Reddy’s Laboratories Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

63. Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors

64. Table Abbott Laboratories Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

65. Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors

66. Table Amgen Bioengineered Protein Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

67. Table Production Base and Market Concentration Rate of Raw Material

68. Table Key Suppliers of Raw Materials

69. Table Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2016

70. Table Major Buyers of Bioengineered Protein Drugs

71. Table Distributors/Traders List

72. Table Global Bioengineered Protein Drugs Production (K Pcs) Forecast by Region (2017-2022)

73. Table Global Bioengineered Protein Drugs Consumption (K Pcs) Forecast by Region (2017-2022)

74. Table North America Bioengineered Protein Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)

75. Table Europe Bioengineered Protein Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)

76. Table China Bioengineered Protein Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)

77. Table Japan Bioengineered Protein Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)

78. Table Southeast Asia Bioengineered Protein Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)

79. Table India Bioengineered Protein Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)

80. Table Global Bioengineered Protein Drugs Production (K Pcs) Forecast by Type (2017-2022)

81. Table Global Bioengineered Protein Drugs Revenue (Million USD) Forecast by Type (2017-2022)

82. Table Global Bioengineered Protein Drugs Price Forecast by Type (2017-2022)

83. Table Global Bioengineered Protein Drugs Consumption (K Pcs) Forecast by Application (2017-2022)

84. Table Research Programs/Design for This Report

85. Table Key Data Information from Secondary Sources

86. Table Key Data Information from Primary Source

---

List Of Figures

1. Figure Picture of Bioengineered Protein Drugs

2. Figure Global Bioengineered Protein Drugs Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)

3. Figure Global Bioengineered Protein Drugs Production Market Share by Types (Product Category) in 2016

4. Figure Product Picture of Monoclonal Antibodies

5. Figure Product Picture of Therapeutic Proteins

6. Figure Product Picture of Vaccines

7. Figure Global Bioengineered Protein Drugs Consumption (K Pcs) by Applications (2012-2022)

8. Figure Global Bioengineered Protein Drugs Consumption Market Share by Applications in 2016

9. Figure Pharma and Biotech Companies Examples

10. Figure CROs Examples

11. Figure Academics Examples

12. Figure Global Bioengineered Protein Drugs Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)

13. Figure North America Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)

14. Figure Europe Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)

15. Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)

16. Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)

17. Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)

18. Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)

19. Figure Global Bioengineered Protein Drugs Revenue (Million USD) Status and Outlook (2012-2022)

20. Figure Global Bioengineered Protein Drugs Capacity, Production (K Pcs) Status and Outlook (2012-2022)

21. Figure Global Bioengineered Protein Drugs Major Players Product Capacity (K Pcs) (2012-2017)

22. Figure Global Bioengineered Protein Drugs Capacity (K Pcs) of Key Manufacturers in 2016

23. Figure Global Bioengineered Protein Drugs Capacity (K Pcs) of Key Manufacturers in 2017

24. Figure Global Bioengineered Protein Drugs Major Players Product Production (K Pcs) (2012-2017)

25. Figure 2016 Bioengineered Protein Drugs Production Share by Manufacturers

26. Figure 2017 Bioengineered Protein Drugs Production Share by Manufacturers

27. Figure Global Market Bioengineered Protein Drugs Average Price (USD/Pcs) of Key Manufacturers in 2016

28. Figure Bioengineered Protein Drugs Market Share of Top 3 Manufacturers

29. Figure Bioengineered Protein Drugs Market Share of Top 5 Manufacturers

30. Figure Global Bioengineered Protein Drugs Capacity Market Share by Region (2012-2017)

31. Figure Global Bioengineered Protein Drugs Capacity Market Share by Region (2012-2017)

32. Figure 2016 Global Bioengineered Protein Drugs Capacity Market Share by Region

33. Figure Global Bioengineered Protein Drugs Production (K Pcs) by Region (2012-2017)

34. Figure Global Bioengineered Protein Drugs Production Market Share by Region (2012-2017)

35. Figure 2016 Global Bioengineered Protein Drugs Production Market Share by Region

36. Figure Global Bioengineered Protein Drugs Revenue Market Share by Region (2012-2017)

37. Figure Global Bioengineered Protein Drugs Capacity, Production (K Pcs) and Growth Rate (2012-2017)

38. Figure Global Bioengineered Protein Drugs Consumption Market Share by Region (2012-2017)

39. Figure 2016 Global Bioengineered Protein Drugs Consumption (K Pcs) Market Share by Region

40. Figure Production Market Share of Bioengineered Protein Drugs by Type (2012-2017)

41. Figure 2016 Production Market Share of Bioengineered Protein Drugs by Type

42. Figure Production Revenue Share of Bioengineered Protein Drugs by Type (2012-2017)

43. Figure 2016 Revenue Market Share of Bioengineered Protein Drugs by Type

44. Figure Global Bioengineered Protein Drugs Production Growth by Type (2012-2017)

45. Figure Global Bioengineered Protein Drugs Consumption Market Share by Applications (2012-2017)

46. Figure Global Bioengineered Protein Drugs Consumption Market Share by Application in 2016

47. Figure Global Bioengineered Protein Drugs Consumption Growth Rate by Application (2012-2017)

48. Figure GlaxoSmithKline Bioengineered Protein Drugs Production Growth Rate (2012-2017)

49. Figure GlaxoSmithKline Bioengineered Protein Drugs Production Market Share (2012-2017)

50. Figure GlaxoSmithKline Bioengineered Protein Drugs Revenue Market Share (2012-2017)

51. Figure Johnson & Johnson Bioengineered Protein Drugs Production Growth Rate (2012-2017)

52. Figure Johnson & Johnson Bioengineered Protein Drugs Production Market Share (2012-2017)

53. Figure Johnson & Johnson Bioengineered Protein Drugs Revenue Market Share (2012-2017)

54. Figure Merck Bioengineered Protein Drugs Production Growth Rate (2012-2017)

55. Figure Merck Bioengineered Protein Drugs Production Market Share (2012-2017)

56. Figure Merck Bioengineered Protein Drugs Revenue Market Share (2012-2017)

57. Figure Novartis Bioengineered Protein Drugs Production Growth Rate (2012-2017)

58. Figure Novartis Bioengineered Protein Drugs Production Market Share (2012-2017)

59. Figure Novartis Bioengineered Protein Drugs Revenue Market Share (2012-2017)

60. Figure Sanofi Bioengineered Protein Drugs Production Growth Rate (2012-2017)

61. Figure Sanofi Bioengineered Protein Drugs Production Market Share (2012-2017)

62. Figure Sanofi Bioengineered Protein Drugs Revenue Market Share (2012-2017)

63. Figure Eli Lilly Bioengineered Protein Drugs Production Growth Rate (2012-2017)

64. Figure Eli Lilly Bioengineered Protein Drugs Production Market Share (2012-2017)

65. Figure Eli Lilly Bioengineered Protein Drugs Revenue Market Share (2012-2017)

66. Figure F. Hoffmann-La Roche Bioengineered Protein Drugs Production Growth Rate (2012-2017)

67. Figure F. Hoffmann-La Roche Bioengineered Protein Drugs Production Market Share (2012-2017)

68. Figure F. Hoffmann-La Roche Bioengineered Protein Drugs Revenue Market Share (2012-2017)

69. Figure Dr. Reddy’s Laboratories Bioengineered Protein Drugs Production Growth Rate (2012-2017)

70. Figure Dr. Reddy’s Laboratories Bioengineered Protein Drugs Production Market Share (2012-2017)

71. Figure Dr. Reddy’s Laboratories Bioengineered Protein Drugs Revenue Market Share (2012-2017)

72. Figure Abbott Laboratories Bioengineered Protein Drugs Production Growth Rate (2012-2017)

73. Figure Abbott Laboratories Bioengineered Protein Drugs Production Market Share (2012-2017)

74. Figure Abbott Laboratories Bioengineered Protein Drugs Revenue Market Share (2012-2017)

75. Figure Amgen Bioengineered Protein Drugs Production Growth Rate (2012-2017)

76. Figure Amgen Bioengineered Protein Drugs Production Market Share (2012-2017)

77. Figure Amgen Bioengineered Protein Drugs Revenue Market Share (2012-2017)

78. Figure Price Trend of Key Raw Materials

79. Figure Manufacturing Cost Structure of Bioengineered Protein Drugs

80. Figure Manufacturing Process Analysis of Bioengineered Protein Drugs

81. Figure Bioengineered Protein Drugs Industrial Chain Analysis

82. Figure Global Bioengineered Protein Drugs Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)

83. Figure Global Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

84. Figure Global Bioengineered Protein Drugs Price (Million USD) and Trend Forecast (2017-2022)

85. Figure Global Bioengineered Protein Drugs Production Market Share Forecast by Region (2017-2022)

86. Figure Global Bioengineered Protein Drugs Consumption Market Share Forecast by Region (2017-2022)

87. Figure North America Bioengineered Protein Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)

88. Figure North America Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

89. Figure Europe Bioengineered Protein Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)

90. Figure Europe Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

91. Figure China Bioengineered Protein Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)

92. Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

93. Figure Japan Bioengineered Protein Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)

94. Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

95. Figure Southeast Asia Bioengineered Protein Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)

96. Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

97. Figure India Bioengineered Protein Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)

98. Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

99. Figure Global Bioengineered Protein Drugs Production (K Pcs) Forecast by Type (2017-2022)

100. Figure Global Bioengineered Protein Drugs Revenue Market Share Forecast by Type (2017-2022)

101. Figure Global Bioengineered Protein Drugs Consumption (K Pcs) Forecast by Application (2017-2022)

102. Figure Bottom-up and Top-down Approaches for This Report

103. Figure Data Triangulation